Delivery Order SPE2DX22D0010-SPE2D825FHP06
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $37,470.85 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive and scheduled for ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,994.94 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed price delivery order, which is effective through July 29, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,538.80 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a child award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $34,138.30 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This non-set-aside competitive award serves as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,161.68 on May 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitively awarded, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,439.40 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025. This firm fixed price, competitively awarded contract (No. 4568932617) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $84,674.22 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,364.95 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025. This firm fixed-price, non-set-aside contract represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order is to be completed by...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,646.92 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHP06Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $40,759.20 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price contract, which is not set-aside, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This award reflects AmerisourceBergen Drug Corp's critical role as a pharmaceutical prime vendor for the Defense Health Agency and other federal healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare programs. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill federal medical supply requirements through open competition, as evidenced by the company's consistent receipt of competitively awarded, non-set-aside delivery orders ranging from nominal amounts to substantial orders exceeding $40,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 8/11/25 |